Life-threatening complications of hepatitis B virus-related polyarteritis nodosa developing despite interferon-alpha2b therapy: successful treatment with a combination of interferon, lamivudine, plasma exchanges and steroids

Clin Rheumatol. 2001;20(4):290-2. doi: 10.1007/s100670170050.

Abstract

Polyarteritis nodosa (PAN) is a rare vasculitis associated with hepatitis B virus (HBV) infection in a significant proportion of cases. When used to treat HBV-related PAN, immunosuppressive agents may enhance viral replication and relaspes are frequent. In recent years the use of antiviral drugs has been proposed. We report the case of a patient with HBV-related PAN who, despite 6 weeks of interferon-alpha2b (IFN-alpha2b) monotherapy, developed life-threatening complications with bowel perforation. He was thereafter successfully treated with a combination of IFN-alpha2b, lamivudine, plasma exchanges and short-term steroids. In contrast to IFN-alpha2b, lamivudine is effective in rapidly suppressing viral replication. This may be valuable in the treatment of HBV-related PAN by contributing to a faster diminution of circulating immune complex levels. This case report highlights the importance of aggressive combined therapy in patients with HBV-related PAN.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Combined Modality Therapy
  • Critical Illness
  • Disease Progression
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Hepatitis B / complications*
  • Hepatitis B / diagnosis
  • Hepatitis B / drug therapy
  • Hepatitis B virus / drug effects
  • Hepatitis B virus / isolation & purification
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Lamivudine / administration & dosage*
  • Plasma Exchange / methods*
  • Polyarteritis Nodosa / diagnosis
  • Polyarteritis Nodosa / therapy*
  • Polyarteritis Nodosa / virology*
  • Recombinant Proteins
  • Risk Assessment
  • Steroids / administration & dosage*
  • Treatment Outcome

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Steroids
  • Lamivudine